Alumis Inc. is a precision medicines company focused on transforming outcomes for autoimmune diseases. We are seeking a PhD-level expert to lead late-stage drug substance development, guide CMC strategy, and manage CDMOs to ensure scalable, compliant manufacturing.
The role requires strong communication and cross-functional collaboration in a fast-paced setting. The candidate will oversee tech transfer, process development, and dosing formulating strategies, with travel up to 25% domestically
#J-18808-LjbffrSenior Scientist, Drug Substance Development (Late-Stage) in south san francisco at Unknown Company
This position is listed as full time and onsite.